share_log

HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co.重申買入Cyclo Therapeutics,維持3美元的目標股價
Benzinga ·  05/31 06:17

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains $3 price target.

HC Wainwright分析師Swayampakula Ramakanth重申買入Cyclo Therapeutics(納斯達克:CYTH)並維持3美元的塔吉特。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論